Trial Profile
A Comparative study on evaluation of vilagliptin based regimen vs dapagliflozen based regimen in type 2 diabetic complications
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 May 2017 New trial record